| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Norway | 7 | |
| #2 | Denmark | 6 | |
| #3 | EPO (European Patent Office) | 6 | |
| #4 | Australia | 5 | |
| #5 | Finland | 5 | |
| #6 | Portugal | 5 | |
| #7 | South Africa | 5 | |
| #8 | China | 4 | |
| #9 | Czechoslovakia | 4 | |
| #10 | Hungary | 4 | |
| #11 | Ireland | 4 | |
| #12 | Israel | 4 | |
| #13 | New Zealand | 4 | |
| #14 | Yugoslavia (Serbia and Montenegro) | 4 | |
| #15 | United Kingdom | 3 | |
| #16 | Greece | 3 | |
| #17 | India | 3 | |
| #18 | Iceland | 3 | |
| #19 | Luxembourg | 3 | |
| #20 | United States | 3 | |
| #21 | Belgium | 2 | |
| #22 | Canada | 2 | |
| #23 | Switzerland | 2 | |
| #24 | German Democratic Republic | 2 | |
| #25 | Germany | 2 | |
| #26 | France | 2 | |
| #27 | Italy | 2 | |
| #28 | Japan | 2 | |
| #29 | Republic of Korea | 2 | |
| #30 | Morocco | 2 | |
| #31 | African Intellectual Property Organization | 2 | |
| #32 | Philippines | 2 | |
| #33 | USSR (Union of Socialist Soviet Republics) | 2 | |
| #34 | Tunisia | 2 | |
| #35 | Bulgaria | 1 | |
| #36 | Spain | 1 | |
| #37 | Poland | 1 | |
| #38 | Romania | 1 | |
| #39 | Russian Federation | 1 | |
| #40 | WIPO (World Intellectual Property Organization) | 1 | |
| #41 | Zambia | 1 | |
| #42 | Zimbabwe | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Margarit Josette | 28 |
| #2 | Franceschini Jacqueline | 27 |
| #3 | Egros Fabrice | 12 |
| #4 | Dufour Alain | 12 |
| #5 | Aiache Jean-Marc | 12 |
| #6 | Ramos Joaquin Alvaro Galiano | 10 |
| #7 | Gardaix-Luthereau Renee | 9 |
| #8 | Acher Jacques | 8 |
| #9 | Besancon Denis | 8 |
| #10 | Galiano Ramos Joaquin Alvaro | 7 |
| Publication | Filing date | Title |
|---|---|---|
| IL95105D0 | Oral pharmaceutical compositions having controlled bioavailability | |
| EP0392922A2 | Use of derivatives of 2-methoxy-4-[4,5-dihydro 2-imidazolyl (or 2 oxazolyl) amino]5-chloro benzamide in the treatment of disorders of the cognitive function | |
| DK613989D0 | Use of substituted benzamides for the preparation of medicinal products with gas tromotoric effect | |
| DK614089D0 | Use of substituted benzamides for the preparation of medicinal products with anxiolytic and antipsycotic effects | |
| EP0295350A2 | Use of N-¬2-(diethylamino)ethyl -2-methoxy-4-¬(1-H 4,5-dihydro-2-imidazolyl)amino -5-chlorobenzamide as an anxiolytic and antipsychotic agent | |
| RO96328B1 | Process for preparing dehydrobenzofuran and chroman-carboxamide derivatives | |
| IE850627L | 1,4-dihydropyridine derivatives,their preparation and their use |